5-Amino-1MQ Protocol Mistakes & Troubleshooting I can't sleep after starting Insomnia is most often linked in reports to evening or midday dosing rather than morning dosing
Human dosing, long-term safety, and drug interactions are not established
Gastrointestinal symptoms: Some peptides, especially GLP-1 receptor agonists such as semaglutide or tirzepatide, can slow digestion, which may lead to nausea, vomiting, diarrhea, or constipation
No dose-ranging study has established a human oral dose for this compound, so the high oral numbers circulate as community and vendor convention rather than as published clinical figures
Informal reports sometimes describe body-composition changes after 4 to 6 weeks, while animal studies measured changes over 11 to 28 days